Y. Yamamoto et al. / Tetrahedron 60 (2004) 10695–10700
10699
128.8, 136.5, 157.5; MS (EI) m/z 41 (53), 59 (15), 69 (10),
84 (45), 91 (15), 121 (100) 134 (46), 161 (11), 262 (14);
HRMS calcd for C15H23BO3; 262.1740, found: 262.1718.
82.7; MS (EI) m/z 43 (23), 69 (44), 82 (30), 85 (26), 110
(30), 124 (100), 129 (23), 195 (38); HRMS calcd for
C12H23BO2; 210.1791, found: 210.1773.
3.2.8. 2-(2-(4-Methylphenyl)ethyl)-4,4,5,5-tetramethyl-
[1,3,2]-dioxaborolane (2h). H NMR (400 MHz, CDCl3)
3.2.15. (exo)-2-(Bicyclo-[2,2,1]-hept-2-yl)-4,4,5,5-tetra-
methyl-[1,3,2]-dioxaborolane (2o). H NMR (400 MHz,
1
1
d 1.12 (t, JZ8.1 Hz, 2H), 1.23 (s, 12H), 2.30 (s, 3H), 2.70 (t,
JZ8.1 Hz, 2H), 7.05–7.12 (m, 4H); 13C NMR (100 MHz,
CDCl3) d 20.9, 24.8, 29.4, 83.0, 127.8, 128.8, 134.8, 141.3;
MS (EI) m/z 41 (67), 59 (21), 69 (16), 84 (100), 105 (63),
118 (23), 146 (16), 189 (6), 246 (9); HRMS calcd for
C15H23BO2; 246.1791, found: 246.1781.
CDCl3) d 0.87–0.94 (m, 1H), 1.23 (s, 12H), 1.14–1.40 (m,
4H), 1.42–1.68 (m, 4H), 2.22–2.29 (m, 2H); 13C NMR
(100 MHz, CDCl3) d 24.7, 29.3, 32.2, 32.2, 36.6, 38.1, 38.7,
82.8; MS (EI) m/z 41 (100), 55 (42), 67 (34), 84 (33), 108
(12), 136 (14), 207 (15), 222 (0.6); HRMS calcd for
C13H23BO2; 222.1791, found: 222.1813.
3.2.9. 2-(2-Pentafluorophenylethyl)-4,4,5,5-tetramethyl-
[1,3,2]-dioxaborolane (2i). H NMR (400 MHz, CDCl3) d
3.2.16. 2-(4-tert-Butyl-cyclohexylmethyl)-4,4,5,5-tetra-
methyl-[1,3,2]-dioxaborolane (2p). H NMR (400 MHz,
1
1
1.10 (t, JZ8.1 Hz, 2H), 1.23 (s, 12H), 2.79 (t, JZ8.1 Hz,
2H); 13C NMR (100 MHz, CDCl3) d 16.9, 24.7, 83.3, 117.1,
138.0, 138.6, 140.5, 143.7, 146.1; MS (EI) m/z 43 (100), 59
(91), 69 (21), 85 (47), 129 (28), 181 (30) 222 (23), 307 (21),
322 (6); HRMS calcd for C14H16BF5O2; 322.1164, found:
322.1185.
CDCl3) d 0.69–1.02 (m, 4H), 0.82 (s, 9H), 1.25 (s, 12H),
1.39–1.57 (m, 5H), 1.69–1.78 (m, 2H), 2.05 (br s, 1H); 13C
NMR (100 MHz, CDCl3) d 21.2, 24.8, 27.5, 28.6, 32.8,
36.3, 48.6, 82.7; MS (EI) m/z 41 (27), 57 (61), 85 (100), 87
(24), 95 (24), 101 (55), 129 (39), 167 (24), 223 (20), 265
(13), 280 (11); HRMS calcd for C17H33BO2; 280.2574,
found: 280.2584.
3.2.10. 2-(2-(2-Naphthyl)ethyl)-4,4,5,5-tetramethyl-
[1,3,2]-dioxaborolane (2j). H NMR (400 MHz, CDCl3) d
1
3.2.17.
2-[3-(tert-Butyldimethylsilyloxy)-2-methyl-
1.23 (t, JZ8.1 Hz, 2H), 1.22 (s, 12H), 2.92 (t, JZ8.1 Hz,
2H), 7.36–7.43 (m, 3H), 7.64 (s, 1H), 7.73–7.79 (m, 3H);
13C NMR (100 MHz, CDCl3) d 24.8, 30.1, 83.1, 124.9,
125.7, 125.7, 127.3, 127.4, 127.5, 127.7, 131.9, 133.6,
142.0; MS (EI) m/z 41 (50), 59 (15), 69 (14), 84 (71), 115
(37), 141 (100), 154 (69), 166 (18), 182 (18), 282 (26);
HRMS calcd for C18H23BO2; 282.1791, found: 282.1774.
propyl]-4,4,5,5-tetramethyl-[1,3,2]-dioxaborolane (2q).
1H NMR (400 MHz, CDCl3) d 0.002 (s, 6H), 0.55 (dd,
JZ8.8, 15.6 Hz, 1H), 0.82–0.85 (m, 1H), 0.86 (s, 9H), 0.87
(d, JZ6.5 Hz, 2H), 1.22 (s, 12H), 1.76–1.89 (m, 1H), 3.28
(dd, JZ7.2, 9.6 Hz, 1H), 3.40 (dd, JZ5.7, 9.6 Hz, 1H); 13C
NMR (100 MHz, CDCl3) d K5.35, 18.3, 19.0, 24.8, 26.0,
32.2, 70.0, 82.8; MS (EI) m/z 75 (24), 115 (23), 101 (11),
115 (23), 157 (100), 257 (23), 299 (2), 313 (0.2); HRMS
calcd for C12H26BO3Si (–tert-butyl); 274.1744, found:
274.1753.
3.2.11. 2-(2-(4-Prydyl)ethyl)-4,4,5,5-tetramethyl-[1,3,2]-
dioxaborolane (2k). 1H NMR (400 MHz, CDCl3) d 1.15 (t,
JZ8.1 Hz, 2H), 1.25 (s, 12H), 2.74 (t, JZ8.1 Hz, 2H),
7.11–7.16 (m, 2H), 8.42–8.58 (m, 2H); 13C NMR
(100 MHz, CDCl3) d 24.7, 29.2, 83.3, 123.5, 149.2, 153.4;
MS (EI) m/z 41 (52), 59 (59), 93 (39), 106 (29), 133 (100),
147 (40), 218 (43), 233 (50); HRMS calcd for C13H20BNO2;
233.1587, found: 233.1576.
3.2.18. 2-(1,2-Dimethyl-propyl)-4,4,5,5-tetramethyl-
[1,3,2]-dioxaborolane (2r). H NMR (400 MHz, CDCl3)
1
d 0.86 (d, JZ6.8 Hz, 6H), 0.90 (d, JZ6.6 Hz, 3H), 1.23–
1.28 (m, 1H), 1.25 (s, 12H), 1.42–4.52 (m, 1H); 13C NMR
(100 MHz, CDCl3) d 11.7, 22.2, 24.8, 32.9, 82.8; MS (EI)
m/z 41 (16), 57 (38), 69 (16), 83 (35), 87 (37), 99 (34), 129
(100), 183 (52), 198 (17); HRMS calcd for C11H23BO2;
198.1791, found: 198.1791.
3.2.12. 2-(1-Butyl)-4,4,5,5-tetramethyl-[1,3,2]-dioxa-
1
borolane (2l). H NMR (400 MHz, CDCl3) d 0.78 (t, JZ
7.7 Hz, 2H), 0.88 (t, JZ7.2 Hz, 3H), 1.25 (s, 12H), 1.27–
1.43 (m, 4H); 13C NMR (100 MHz, CDCl3) d 13.8, 24.7,
25.3, 26.1, 82.7; MS (EI) m/z 43 (16), 59 (24), 85 (50), 129
(62), 169 (100), 184 (3); HRMS calcd for C10H21BO2;
184.1635, found: 184.1638.
References and notes
3.2.13. 4,4,5,5-Tetramethyl-2-(3-phenyl-propyl)-[1,3,2]-
dioxaborolane (2m). H NMR (400 MHz, CDCl3) d 0.83
1. (a) Onak, T. Organoborane Chemistry; Academic: New York,
1975. (b) Mikhailov, B. M.; Bubnov, Y. N. Organoboron
Compounds in Organic Synthesis; Harwood Academic:
Amsterdam, 1983. (c) Pelter, A.; Smith, K.; Brown, H. C.
Borane Reagents; Academic: London, 1988. (d) Smith, K.;
Pelter, A. Comprehensive Organic Synthesis; Trost, B. M.,
Fleming, I., Eds.; Pergamon: Oxford, 1991; Vol. 8, p 703. (e)
Matteson, D. Stereodirected Synthesis with Organoboranes;
Springer: Berlin, 1995. (f) Vaultier, M.; Carboni, B.
Comprehensive Organometallic Chemistry II; Abel, E. W.,
Stone, F. G. A., Wilkinson, G., Eds.; Pergamon: Oxford, 1995;
Vol. 8, p 191.
1
(t, JZ7.8 Hz, 2H), 1.24 (s, 12H), 1.73 (tt, JZ7.8, 7.9 Hz,
2H), 2.60 (t, JZ7.9 Hz, 2H), 7.14–7.21 (m, 3H), 7.24–7.26
(m, 2H); 13C NMR (100 MHz, CDCl3) d 24.8, 26.1, 38.6,
82.9, 125.5, 128.1, 128.5, 142.7; MS (EI) m/z 41 (22), 59
(10), 85 (100), 91 (62), 118 (93), 127 (24), 146 (13), 173
(12), 231 (11), 246 (32); HRMS calcd for C15H23BO2;
246.1791, found: 246.1796.
3.2.14. 2-(Cyclohexyl)-4,4,5,5-tetramethyl-[1,3,2]-dioxa-
borolane (2n). H NMR (400 MHz, CDCl3) d 0.93–1.04
1
¨ ¨
2. Manning, D.; Noth, H. Angew. Chem., Int. Ed. Engl. 1985, 24,
878.
(m, 1H), 1.23 (s, 12H), 1.26–1.36 (m, 4H), 1.54–1.70 (m,
6H); 13C NMR (100 MHz, CDCl3) d 24.7, 26.7, 27.1, 28.0,